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Abstract 
Guanethidine displaces noradrenaline from sympathetic varicosities, and blocks 
sympathetic noradrenergic neurotransmission by inhibiting the release of 
noradrenaline from depleted neural stores. The aim of this study was to determine 
whether depletion of noradrenaline with guanethidine would oppose thermal 
hyperalgesia and/or electrically-evoked pain in mildly-burnt skin. Guanethidine was 
transferred by iontophoresis into a small patch of skin on the forearm of 35 healthy 
human subjects. The heat pain threshold to a temperature gradient that increased at 
0.5oC/s was then measured at the guanethidine site, a nearby saline-control 
iontophoresis site, and in untreated skin. In addition, participants rated pain intensity 
to a 47oC stimulus that was applied to each site for 7 s. Shortly after the 
iontophoreses, sensitivity to heat was greater at the guanethidine site than the two 
control sites, suggesting that ejection of noradrenaline from sympathetic varicosities 
increased sensitivity to heat. One day later, when neural stores of noradrenaline were 
depleted, sensitivity to heat did not differ between the guanethidine and control sites. 
The guanethidine pretreatment did not influence thermal hyperalgesia induced by a 
mild burn, but inhibited pain evoked by electrical stimulation of the skin (0.2 mA 
direct current for 4 minutes). These findings indicate that ongoing sympathetic neural 
discharge does not normally influence thermal hyperalgesia in inflamed skin, because 
depleting noradrenergic stores had no effect. However, electrically-evoked release of 
noradrenaline may increase nociceptive sensations. Further clarification of this human 
pain model could provide insights into the mechanism of adrenergic hyperalgesia in 
certain neuropathic pain syndromes. 
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Introduction 
 Sympathetic neural discharge does not normally excite primary nociceptive 
afferents. However, electrophysiological experiments in animals have demonstrated 
that primary afferent nociceptors develop sensitivity to adrenergic agents during 
inflammation and after nerve injury. For example, after nerve transection, stimulation 
of the sympathetic chain and local injection of α-adrenergic agonists excites sensory 
fibres within the resultant neuroma (Burchiel, 1984). Adrenergic agonists also excite 
dorsal root fibres excised two weeks after chronic loose constriction of the sciatic 
nerve (Zhang et al., 1997), and excite uninjured fibres that survive partial destruction 
of the sciatic nerve (Sato and Perl, 1991; Ali et al., 1999). Similarly, stimulation of the 
sympathetic chain and intra-arterial injection of adrenergic agonists provokes 
hyperalgesia and discharge of primary nociceptive afferents in inflamed tissue (Hu 
and Zhu, 1989; Sato et al., 1993; Baik et al., 2003). Conversely, blockade of α1-
adrenergic receptors blocks C-fibre discharge to mechanical stimulation of cutaneous 
fibres sensitized by intradermal injection of capsaicin (Ren et al., 2005). 
 Studies in humans also indicate that adrenergic agents influence hyperalgesia 
in inflamed skin. For example, blockade of α-adrenergic receptors inhibits ongoing 
and mechanically-evoked pain in skin sensitized by an intradermal injection of 
capsaicin (Kinnman et al., 1997). Conversely, thermal hyperalgesia is augmented by 
iontophoresis of noradrenaline into skin made sensitive to heat by the topical 
application of capsaicin (Drummond, 1995). This adrenergic hyperalgesia is blocked 
by α-adrenergic antagonists and persists after arterial occlusion (Drummond, 1996; 
Drummond, 1998a; Drummond, 1999).  
 Tyramine displaces noradrenaline from the synaptic vesicles and cytoplasm of 
sympathetic nerve fibres (Smith, 1973), and augments sensitivity to heat in skin 
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already sensitized by the topical application of capsaicin (Drummond, 1998b). Like 
tyramine, guanethidine displaces noradrenaline from sympathetic varicosities (Chang 
et al., 1965), but guanethidine also blocks sympathetic noradrenergic 
neurotransmission by activating potassium channels in the neural membrane (Fabiani 
and Story, 1996). Displacing noradrenaline from sympathetic varicosities with 
guanethidine takes around three hours (McKain et al., 1983), and replenishing these 
neural stores requires several days (Lipnicki and Drummond, 2001).  
In a previous study in our laboratory, repeated administration of guanethidine 
over a two-week period induced vascular signs of adrenergic supersensitivity 
(Lipnicki and Drummond, 2001), presumably due to an up-regulation of adrenergic 
receptors during prolonged sympathetic blockade. In addition, the guanethidine 
pretreatment augmented thermal hyperalgesia induced by the iontophoresis of 
noradrenaline in capsaicin-treated skin, suggesting that stimulation of the up-regulated 
adrenergic receptors intensified sensitivity to heat.  
The aim of the present study was to extend these findings by investigating the 
short-term effects of guanethidine on thermal hyperalgesia. In particular, it was 
hypothesized that an initial efflux of noradrenaline into the skin, provoked by 
guanethidine, would increase sensitivity to heat. To test this hypothesis, sensitivity to 
heat was investigated shortly after guanethidine was transferred by iontophoresis into 
a small patch of skin on the forearm of healthy human subjects. One day later, when 
neural stores of noradrenaline were depleted, sensitivity to heat was investigated 
before and after heat-sensitization induced by a mild burn, to determine whether 
depletion of noradrenaline at the guanethidine-pretreated site would inhibit sensitivity 
to heat. In some cases the heat-sensitized skin was also stimulated electrically with a 
0.2 mA direct current. It was hypothesized that electrically-evoked release of 
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noradrenaline from sympathetic nerve terminals would augment nociceptive 
sensations, and that adrenergic depletion with guanethidine would block this effect. 
Method 
Subjects 
 Participants were aged between 18 and 58 years and were free of chronic pain 
or any other major medical condition. Each subject provided their informed consent 
for the procedures, which were approved by the Murdoch University Human Research 
Ethics Committee.  
Procedure 
 The procedures were administered in a temperature-controlled room 
maintained at 21 + 1oC. In the first session, the immediate effect of local guanethidine 
administration on sensitivity to heat was compared with sensitivity to heat at a saline-
control site and an untreated site in the same forearm (N=35). The effect of depleting 
noradrenaline on sensitivity to heat before and after a mild burn was investigated in a 
second session one day later in 25 of these subjects. In the last 16 subjects tested, the 
effect of the guanethidine pretreatment on sensations induced by electrical stimulation 
was also investigated. In previous studies in our laboratory (e.g., Drummond, 1995; 
Drummond, 1996; Drummond, 1998a; Drummond, 1998b; Drummond, 1999; 
Lipnicki and Drummond, 2001), significant effects of noradrenaline and guanethidine 
on sensitivity to heat were identified in samples of 20 or fewer subjects. Thus, the 
sample size in the present study was considered to be large enough to provide an 
adequate test of the hypotheses. 
Session 1: guanethidine administration. Guanethidine hydrochloride (Sigma 
Chemical Company, Sydney, Australia) was dissolved in de-ionized water to form a 
10 mM solution. In the first session, guanethidine ions were transferred by 
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iontophoresis from the 10 mM solution into a small patch of skin on the participant’s 
right or left forearm. To investigate any nonspecific effects of iontophoresis, a control 
procedure involving iontophoresis of 0.9% saline was also carried out at another site 
in the forearm. The site location and order of guanethidine and saline iontophoreses 
were randomized across subjects. The iontophoresis chambers had an internal 
diameter of 2 cm, and were fixed at least 10 cm apart on the forearm with adhesive 
washers. A constant current of 0.1 mA simultaneously passed through the 
guanethidine and saline solutions in the chambers for 30 minutes, to repel positively-
charged ions from the solution into the underlying skin. To complete the electric 
circuits, a cathode was attached to the back of the hand. The dose of guanethidine 
delivered by this current blocks local vasoconstriction to tyramine for several days 
(Lipnicki and Drummond, 2001), consistent with neural depletion of noradrenaline 
(Chang et al., 1965; Fabiani and Story, 1996).  
 Session1: assessment of sensitivity to heat. Fifteen minutes after the 
iontophoreses, sensitivity to heat was measured at the guanethidine site and at two 
control sites (the saline site and untreated skin several cm away from the other sites). 
Heat was delivered from a custom-built servo-controlled thermode containing a 
Peltier element (contact diameter 2 cm). The thermode was held against the skin for 
10-15 s to bring the skin temperature to 32oC, then increased at 0.5oC/s to a maximum 
of 49oC or to the heat-pain threshold. Participants were informed that sensations at the 
site of stimulation would change from warmth to heat, and then to stinging or burning 
pain. They were instructed to press a key to prevent further heating at the onset of 
pain. The heat pain threshold was calculated from three temperature ramps at each 
site. The thermode was then heated to 47oC and applied once at each site for 7 s. 
Participants rated pain intensity verbally between 0 and 10 where 0 corresponded to 
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“not painful”, 5 to “moderately painful”, and 10 to “extremely painful”. Sensitivity to 
heat was investigated once more at each site using the same procedures after an 
interval of 15 minutes, to investigate the stability of responses.  
 Session 2: assessment of sensitivity to heat before and after a mild burn. When 
participants returned to the laboratory one day later, heat pain thresholds were 
measured as described above at the guanethidine site and the two control sites (saline 
and untreated skin). Participants also rated the intensity of pain induced by a 45oC 
stimulus applied once at each site for 7 s (45oC was used instead of 47oC to avoid 
ceiling effects on pain ratings later in the session). Next, the thermode was heated to 
48oC, and pain intensity was monitored while the thermode was applied to one of the 
three sites (tested in random order) for two minutes to induce a mild burn. Thirty 
minutes later, the heat pain threshold and pain ratings to the 45oC stimulus were 
obtained at that site. The same procedures were repeated at the other two sites. 
 Session 2: assessment of electrically-evoked sensations. For each site in turn, a 
0.2 mA direct current was delivered from an iontophoresis chamber (2 cm diameter) 
filled with 0.9% saline. Pain induced by the electric current was rated between 0-10 at 
one-minute intervals for four minutes.  
Data analysis 
 The immediate effect of the guanethidine iontophoresis on heat pain 
thresholds and heat pain ratings in Session 1 was investigated in 3 x 2 [Site 
(guanethidine, saline, untreated) x Time (15 and 30 minutes after the iontophoreses)] 
repeated measures analyses of variance. To avoid violations of the sphericity 
assumption, the multivariate solution was used for effects with more than two levels 
(Vasey and Thayer, 1987).  
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 The delayed effect of the guanethidine iontophoresis on heat pain thresholds 
and heat pain ratings in Session 2 was investigated in 3 x 2 [Site (guanethidine, saline, 
untreated) x Time (before and after heating the skin to 48oC)] repeated measures 
analyses of variance. Mean pain ratings during the 48oC stimulus and pain ratings 
during each minute of electrical stimulation were compared across the three sites in 
repeated measures analyses of variance. In the latter analysis, the Greenhouse-Geisser 
epsilon was applied to the degrees of freedom to correct for violations of the 
sphericity assumption, because N was too small to use the multivariate approach 
(Vasey and Thayer, 1987). 
 The criterion of statistical significance was p<0.05. Significant main effects 
and interactions were investigated with a priori (i.e., “planned”) contrasts between the 
guanethidine site (the experimental site) and each of the two control sites. Data are 
reported as the mean + standard error. 
Results 
Session1: Immediate effect of the guanethidine iontophoresis 
 As shown in Figure 1A, the heat pain threshold was lower at the guanethidine 
site than at the saline site or in untreated skin [main effect for Site, F(2,33) = 40.2, 
p<0.001; mean difference between the guanethidine and untreated sites 2.5 + 0.3oC, 
F(1,34)=77.6, p<0.001; mean difference between the guanethidine and saline sites 2.3 
+ 0.3oC, F(1,34)=76.7, p<0.001]. The heat pain threshold increased during the 15 
minute interval between measures, particularly at the guanethidine site [Site x Time 
interaction, F(2,33)=16.7, p<0.001]. However, recovery was not complete – the heat 
pain threshold remained lower at the guanethidine site than at the other two sites at the 
end of the session [mean difference between the guanethidine and untreated sites 2.0 
+ 0.3oC, F(1,34)=58.4, p<0.001; mean difference between the guanethidine and saline 
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sites 1.8 + 0.3oC, F(1,34)=46.8, p<0.001]. The heat pain threshold did not differ 
significantly between the saline and untreated sites. 
 As shown in Figure 1B, pain ratings to the 47oC stimulus averaged 7.2 
(corresponding to between moderately and extremely painful) at the guanethidine site 
compared with 5.4 at the saline site and 5.0 in untreated skin [main effect for Site, 
F(2,33) = 37.5, p<0.001; mean difference between the guanethidine and untreated 
sites 2.2 + 0.3, F(1,34)=68.2, p<0.001; mean difference between the guanethidine and 
saline sites 1.8 + 0.2, F(1,34)=68.5, p<0.001]. In addition, pain ratings were slightly 
greater at the saline site than in untreated skin [mean difference between the saline 
and untreated sites 0.4 + 0.2, F(1,34)=5.14, p<0.05]. Ratings did not change 
significantly during the 15 minute interval between tests. 
Session 2: Effect of the guanethidine iontophoresis one day later 
 Sensitivity to heat did not differ significantly among the three sites before the 
burn induction (Figure 2), indicating that thermal hyperalgesia at the guanethidine-
pretreated site had subsided.  Pain ratings averaged 7.6 + 0.3 during the 48oC burn, 
and were similar at each site. An increased sensitivity to heat was detected at all three 
sites 30 minutes after the 48oC stimulus [mean decrease in the heat pain threshold 1.5 
+ 0.4oC, F(1,24)=16.7, p<0.001; mean increase in heat pain ratings 2.8 + 0.3, 
F(1,24)=107.9, p<0.001] (Figure 2), consistent with the induction of a mild burn. The 
sensitization to heat was slightly greater at the reference site than at the two pretreated 
sites [Site x Time interaction for the heat pain threshold, F(2,23)=4.03, p<0.05; Site x 
Time interaction for heat pain ratings, F(2,23)=5.57, p<0.05]. Investigation of these 
interactions indicated that decreases in the heat pain threshold after the burn injury 
were smaller at the guanethidine site than the reference site [1.1 + 0.4oC versus 2.0 + 
0.4oC, F(1,24)=6.30, p<0.05], but were similar at the guanethidine and saline sites 
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(Figure 2). The increase in heat pain ratings at the guanethidine site was similar to 
increases at the two control sites, indicating that the interaction was due to a greater 
increase in pain ratings at the reference site than the saline site [3.3 + 0.3 versus 2.4 + 
0.4, F(1,24)=9.31, p<0.01]. 
As shown in Figure 3, pain ratings to electrical stimulation were lower at the 
heat-sensitized guanethidine site than at the two control sites, although the strength of 
this effect varied across the four minutes of stimulation [Site x Time interaction, 
F(3.3, 49.1)=2.74, p<0.05]. Ratings were significantly lower at the guanethidine site 
than at the saline site during the first minute [F(1,15)=5.12, p<0.05], and lower than at 
the reference site during the third [F(1,15)=9.00, p<0.01] and fourth minutes 
[F(1,15)=9.57, p<0.01]. 
Discussion 
 The findings of this study can be summarized as follows. Guanethidine had a 
marked excitatory effect on sensitivity to heat for at least 30 minutes. One day later 
the guanethidine pretreatment had little effect on sensitivity to heat before, during or 
after the induction of a mild burn. However, the guanethidine pretreatment inhibited 
electrically-evoked pain in the burnt skin. 
Immediate effect of the guanethidine iontophoresis  
 The immediate increase in sensitivity to heat appeared to be a specific effect of 
guanethidine, because an iontophoresis of saline for the same duration and current 
intensity at an adjacent control site had only a minor effect on thermal sensations. 
Thermal hyperalgesia persisted for at least 30 minutes after the guanethidine 
administration, although an increase in the heat pain threshold at 30 minutes suggests 
that hyperalgesia was starting to wane. One day later, thermal hyperalgesia had 
disappeared completely at the site of guanethidine administration. This is consistent 
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with the three-hour time course of adrenergic displacement after guanethidine 
administration (McKain et al., 1983; Lipnicki and Drummond, 2001).  
 Since guanethidine ejects noradrenaline from sympathetic varicosities (Chang 
et al., 1965), it seems likely that an efflux of noradrenaline into the skin during and 
after the administration of guanethidine increased sensitivity to heat. Indeed, 
intradermal administration of adrenergic agents by iontophoresis or injection increases 
thermal hyperalgesia in non-inflamed skin (Drummond, 1996; Fuchs et al., 2001). The 
hyperalgesia does not seem to be due to adrenergic vasoconstriction (Drummond, 
1996; Fuchs et al., 2001), but could be mediated by an increased production of 
nociceptive mediators such as prostaglandins or nerve growth factor (Levine et al., 
1986; Gonzales et al., 1989; Tuttle et al., 1993) or might even involve direct 
excitation of adrenergic receptors on the peripheral projections of primary nociceptive 
afferents. Messenger RNA for α1-adrenoceptors is present in the superficial dorsal 
horn and dorsal root ganglia of rats (Nicholson et al., 2005). Moreover, adrenergic 
agents such as noradrenaline and phenylephrine increase the excitability of cultured 
dorsal root ganglion neurons (Kasai and Mizumura, 2001; Pluteanu et al., 2002), 
suggesting that primary sensory afferents contain α-adrenoceptors. 
Delayed effect of the guanethidine iontophoresis  
Injection of adrenergic agents and stimulation of the sympathetic chain 
influence the discharge of nociceptive afferents in the inflamed skin of anaesthetized 
animals (e.g., Hu and Zhu, 1989; Sato et al., 1993; Baik et al., 2003), but normal 
variations in sympathetic activity generally do not exacerbate pain or hyperalgesia in 
the inflamed skin of healthy, awake humans (Pedersen et al., 1997; Baron et al., 1999; 
Elam et al., 1999; Drummond, 2001). In fact, thermal hyperalgesia in capsaicin-
treated skin decreases during sympathetically-arousing tasks in healthy adults 
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(Drummond et al., 2001). Importantly, however, blockade of α-adrenergic receptors 
inhibits ongoing pain, nociceptive discharge and mechanical hyperalgesia in skin 
sensitized by an intradermal injection of capsaicin (Kinnman et al., 1997; Ren et al., 
2005). Taken together, these findings suggest that inhibitory pain modulation 
processes override excitatory adrenergic influences on nociceptive activity during 
sympathetic vasoconstrictor discharge, except in the presence of a powerful mediator 
of nociceptor sensitization and neurogenic inflammation such as intradermal capsaicin 
(Kinnman et al., 1997). This might explain why depleting adrenergic stores did not 
affect sensitivity to heat one day after guanethidine administration in the present 
study, either before or after the induction of a mild burn. 
It was hypothesized that local electrically-evoked release of noradrenaline 
from sympathetic nerve terminals would augment nociceptive sensations, and that the 
guanethidine pretreatment would block this effect. In support of this hypothesis, 
electrical stimulation of the heat-sensitized skin evoked less pain at the guanethidine-
pretreated site than at the two control sites, although this varied over the four minutes 
of stimulation. Pain peaked during the first minute of electrical stimulation but then 
subsided, possibly due to adaptation of nociceptive afferents. Pain initially was greater 
at the saline than guanethidine site but, for unknown reasons, pain then subsided 
rapidly at the saline site. Pain also decreased more rapidly at the guanethidine-treated 
site than the reference site over the four minutes of stimulation. The guanethidine 
apparently did not inhibit nociceptive discharge directly, because thermal 
hyperalgesia was equivalent at the guanethidine and control sites.  
One explanation for these findings is that noradrenaline, released locally from 
sympathetic varicosities during electrical stimulation, augmented electrically-evoked 
pain in inflamed skin. The sensations evoked by the electrical current were variously 
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described as “pricking”, “stinging”, “sharp”, or “burning”, implying that the current 
excited Aδ and C nociceptive afferents (Schady et al., 1983; Ochoa and Torebjörk, 
1989). Excitation of nociceptive afferents by electrical currents provokes cutaneous 
vasodilatation and neurogenic inflammation (Drummond and Lipnicki, 1999; Magerl 
et al., 1987; Chahl, 1988) which, in turn, may disrupt the blood-nerve barrier 
(Antonijevic et al., 1995). Indeed, disruption of the blood-nerve barrier during 
capsaicin- or heat-evoked inflammation may facilitate thermal hyperalgesia and axon-
reflex vasodilatation to noradrenaline (Drummond, 1998b; Houghton et al., 2006). 
Further studies (e.g., employing microdialysis fibres) could help to clarify whether 
electrical stimulation of the skin induces the local release of noradrenaline, and 
whether electrically-evoked neurogenic inflammation augments nociceptive 
sensations and axon-reflex vasodilatation to noradrenaline.   
If electrical currents excite local nociceptive and sympathetic nerve fibres, it 
might be expected that hyperalgesia would generally develop during transcutaneous 
iontophoresis. In fact, heat pain ratings to a 47oC stimulus were slightly greater at the 
saline site than in untreated skin after the 30-minute saline iontophoresis in the present 
study; however, the iontophoresis had little effect on heat pain thresholds. The 
electrical current was delivered at 32 µA/cm2 during the 30-minute iontophoresis. A 
greater current density or concurrent inflammation might increase sensitivity to heat, 
because heat pain thresholds were lower at a site of saline iontophoresis than at a 
reference site in capsaicin-inflamed skin following electrical stimulation at 99 µA/cm2 
for 1 minute (Drummond, 1999) or 10 minutes (Drummond, 1998a).  
Unlike other forms of neural stimulation, electrical currents can act proximal 
to nerve terminals. After being taken up into the cytoplasm, guanethidine inhibits 
depolarization by opening potassium channels in noradrenergic neurons (Fabiani and 
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Story, 1996). Although the effects of guanethidine probably are greatest at adrenergic 
nerve terminals, guanethidine might also affect neural activity more proximally due to 
diffusion within the cytoplasm. Further studies are required to determine whether 
guanethidine blocks release of noradrenaline within nerve fascicles. From an 
anatomical perspective, the close proximity of adrenergic and nociceptive fibres 
within nerve fascicles might assist their interaction during inflammation. 
Clinical implications  
The present findings indicate that iontophoresis of guanethidine initially 
provoked substantial adrenergic thermal hyperalgesia, followed by loss of thermal 
hyperalgesia and a reduction in electrically-evoked nociceptive sensations when stores 
of noradrenaline were depleted. In a subgroup of patients with complex regional pain 
syndrome (CRPS), pain and hyperalgesia decrease after sympathetic blockade of the 
affected limb (Price et al., 1998), and the pain can be rekindled by intradermal 
injection of adrenergic agonists (Davis et al., 1991; Torebjork et al., 1995; Ali et al., 
2000). Moreover, spontaneous pain and the cutaneous distribution of mechanical 
dynamic and punctate hyperalgesia increase during body cooling (a strong stimulus 
for increased sympathetic vasoconstrictor activity) (Baron et al., 2002), presumably 
due to an interaction between sympathetic adrenergic neurons and nociceptive 
afferents in the skin. In such patients, sympathetic blockade usually prevents increases 
in pain during sympathetic arousal (Drummond and Finch, 2004). Further 
investigation of the effects of guanethidine on nociceptive sensations may help to 
clarify the mechanism of adrenergic hyperalgesia both in normal individuals and in 
patients with neuropathic pain syndromes such as CRPS. 
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Figure legends 
Figure 1. Sensitivity to heat at sites of guanethidine iontophoresis (black bars), saline 
iontophoresis (gray bars), and in untreated skin (clear bars) 15 and 30 minutes after 
the iontophoreses (N = 35). A. The heat pain threshold was lower at the site of 
guanethidine iontophoresis than at the other two sites (* p<0.001). B. Heat pain 
ratings to a 7-s 47oC stimulus were greater at the site of guanethidine iontophoresis 
than at the other two sites (* p<0.001). In addition, heat pain ratings were greater at 
the saline site than the untreated site (# p<0.05). In Figures 1-3, error bars represent 
standard errors. 
Figure 2. Sensitivity to heat 24 hours after the iontophoreses at the guanethidine 
(black bars) and saline sites (gray bars) and in untreated skin (clear bars), before and 
30 minutes after heating each site to 48oC (N = 25). A. The heat pain threshold did not 
differ significantly among the sites, either before or after inducing a mild burn with a 
48oC stimulus. However, the decrease in the heat pain threshold after the burn injury 
was smaller at the guanethidine site than in untreated skin (p<0.05). B. Heat pain 
ratings to a 7-s 45oC stimulus did not differ significantly among the sites, either before 
or after the 48oC stimulus. The increase in heat pain ratings at the guanethidine site 
was similar to increases at the other two sites. However, increases were greater at the 
untreated site than the saline site (p<0.01). 
Figure 3. Mean pain ratings to four minutes of electrical stimulation at the heat-
sensitized guanethidine (black bars), saline (gray bars) and untreated sites (clear bars) 
(N = 16). Pain ratings were significantly lower at the guanethidine site than at the 
saline site during the first minute (* p<0.05), and lower than at the untreated reference 
site during the third and fourth minutes (** p<0.01). 
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